InvestorsHub Logo
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

Re: clawmann post# 1237

Wednesday, 12/15/2010 8:24:20 PM

Wednesday, December 15, 2010 8:24:20 PM

Post# of 22684
I agree with you. I think that unless you dig deeper than the surface of the story, it appears that Loc is DOA as Dew claimed a while back. Especially in light of contrave getting the panel nod, I think Loc has a decent chance at approval. The stock price shows essentially no value for the drug what so ever. My basis is $1.80 and I am taking a chance that the FDA meeting produces something positive for ARNA. We shall see sooner than later